These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 779588)

  • 1. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
    Tahiliani R; Khokhani RC; Damle VB; Dadkar VN; Jaguste VS; Patel K; Raghu CN; Oke VG
    Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind clinical trial of xipamid and hydrochlorothiazide in essential hypertension.
    Kumar S; Pandhi P; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):549-51. PubMed ID: 6392119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
    Louis WJ; Vajda FJ; McNeil JJ; Doyle AE; Jarrott B
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():17-22. PubMed ID: 354826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyldopa in the elderly hypertensive.
    MacFarlane JP
    Curr Med Res Opin; 1982; 7(Suppl 1):63-7. PubMed ID: 7049582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyldopa: single daily dose versus multiple daily dose.
    Yang C; Gurwich E; Kanada S; Nascimento L
    Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind studies of the clinical effectiveness of prazosin.
    Schnaper HW; Oberman A
    Postgrad Med; 1975 Nov; Spec No():81-7. PubMed ID: 1105489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.